Wed, October 19, 2022
Tue, October 18, 2022
Mon, October 17, 2022
Sat, October 15, 2022
Fri, October 14, 2022

Matt Miksic Initiated (ZBH) at Sell and Held Target at $104 on, Oct 18th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ell-and-held-target-at-104-on-oct-18th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matt Miksic of Barclays, Initiated "Zimmer Biomet Holdings, Inc." (ZBH) at Sell and Held Target at $104 on, Oct 18th, 2022.

Matt has made no other calls on ZBH in the last 4 months.



There are 7 other peers that have a rating on ZBH. Out of the 7 peers that are also analyzing ZBH, 4 agree with Matt's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Richard Newitter of "Truist Securities" Maintained at Hold with Increased Target to $125 on, Wednesday, August 3rd, 2022
  • Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $120 on, Wednesday, August 3rd, 2022
  • Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $119 on, Wednesday, August 3rd, 2022
  • Matthew O'Brien of "Piper Sandler" Maintained at Hold with Decreased Target to $120 on, Tuesday, August 2nd, 2022


These are the ratings of the 3 analyists that currently disagree with Matt


  • Matthew Taylor of "Jefferies" Initiated at Sell and Held Target at $95 on, Wednesday, October 12th, 2022
  • Jeff Johnson of "Baird" Maintained at Buy with Decreased Target to $138 on, Tuesday, August 2nd, 2022
  • Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $120 on, Monday, July 18th, 2022

Publication Contributing Sources